Literature DB >> 26770586

Determination of the normative values of the masseter muscle by single-fiber electromyography in myasthenia gravis patients.

Lei Shi1, Heng-Fang Liu1, Min Zhang1, Ya-Pei Guo1, Bo Song2, Chang-Dong Song1, Dan-Dan Song1, Yu-Ming Xu2.   

Abstract

The purpose of this study is to obtain normative values of the masseter muscle of myasthenia gravis (MG) patients and healthy volunteers by single-fiber electromyography (SFEMG). Stimulation of SFEMG in the masseter muscle was studied in 15 healthy volunteers (men 8, women 7; mean age 40.2, range 21-77) and 30 patients affected by MG (men 16, women 14; mean age 42.8, range 12-75). The mean consecutive difference (MCD) of the individual fiber and the mean MCD per study were determined in the normal group. We recommend the upper normal limit for the individual fibers of jitter and the mean MCD per study in the healthy Chinese adults of 33 µs and 22 µs respectively. Furthermore, in the MG group, the percentage of jitter > upper normal limit jitter and the impulse blocking percentage were detected, which were all significantly different compared to the normal control group (P < 0.01). The overall sensitivity was 90%, with the abnormality in 6 of the 9 ocular MG patients and 100% abnormality in the generalized MG patients. The masseter muscle SFEMG has a high degree of sensitivity. The masseter should be considered for SFEMG in the diagnosis of MG, and added routinely to the tested muscles.

Entities:  

Keywords:  Single-fiber electromyography; masseter muscle; myasthenia gravis

Year:  2015        PMID: 26770586      PMCID: PMC4694486     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

Review 1.  Clinical impact of single-fiber electromyography.

Authors:  Donald B Sanders
Journal:  Muscle Nerve Suppl       Date:  2002

2.  Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis.

Authors:  Y Nemoto; S Kuwabara; S Misawa; N Kawaguchi; T Hattori; M Takamori; A Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

Review 3.  Surgery of myasthenia gravis associated or not with thymoma: a retrospective study of 43 cases.

Authors:  Massine El Hammoumi; Adil Arsalane; Fayçal El Oueriachi; El Hassane Kabiri
Journal:  Heart Lung Circ       Date:  2013-03-30       Impact factor: 2.975

4.  Impairment of neuromuscular transmission in transient global amnesia - does it really exist?

Authors:  Małgorzata Gaweł; Izabela Domitrz; Wojciech Domitrz; Elżbieta Szmidt-Sałkowska; Anna Kamińska
Journal:  Neurol Neurochir Pol       Date:  2014-09-10       Impact factor: 1.621

5.  A comparison of electrodiagnostic tests in ocular myasthenia gravis.

Authors:  Hans D Katzberg; Vera Bril
Journal:  J Clin Neuromuscul Dis       Date:  2005-03

6.  Single-fiber electromyography of masseter muscle in myasthenia gravis.

Authors:  Adnan J Khuraibet; Rossen T Rousseff; Raed Behbehani; Asmahan F K al-Shubaili; Riyadh A Khan
Journal:  Muscle Nerve       Date:  2008-04       Impact factor: 3.217

Review 7.  Clinical evaluation and management of myasthenia gravis.

Authors:  John C Keesey
Journal:  Muscle Nerve       Date:  2004-04       Impact factor: 3.217

8.  Clinical aspects of MuSK antibody positive seronegative MG.

Authors:  D B Sanders; K El-Salem; J M Massey; J McConville; A Vincent
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

9.  Electrodiagnostic approach to the patient with suspected neuromuscular junction disorder.

Authors:  Bashar Katirji; Henry J Kaminski
Journal:  Neurol Clin       Date:  2002-05       Impact factor: 3.806

10.  Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study.

Authors:  J B Andersen; J F Owe; A Engeland; N E Gilhus
Journal:  Eur J Neurol       Date:  2014-04-09       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.